CytomX Therapeutics, Inc. short interest in 2024
In 2024, CytomX Therapeutics, Inc.'s disclosed short interest ran from 1.97% of shares outstanding on 12 Jan 2024 to 6.13% on 31 Dec 2024, a change of +4.16 percentage points. The year's high was 12.92% on 15 May 2024 and its low 1.87% on 31 Jan 2024, averaging 7.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.13 days on 30 Aug 2024. Full history: CytomX Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.97% (12 Jan 2024)
- End of year
- 6.13% (31 Dec 2024)
- Change
- +4.16 pp
- High
- 12.92% (15 May 2024)
- Low
- 1.87% (31 Jan 2024)
- Average
- 7.25%
- Highest days to cover
- 15.13 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.97% | 2.27 | |
| 31 Jan 2024 | 1.87% | 4.37 | |
| 15 Feb 2024 | 1.95% | 6.47 | |
| 29 Feb 2024 | 2.42% | 1.00 | |
| 15 Mar 2024 | 5.21% | 2.33 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 4.91% | 3.81 | |
| 15 Apr 2024 | 5.31% | 5.72 | |
| 30 Apr 2024 | 5.31% | 10.41 | |
| 15 May 2024 | 12.92% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.67% | 4.13 | |
| 14 Jun 2024 | 11.46% | 3.03 | |
| 28 Jun 2024 | 11.89% | 3.86 | |
| 15 Jul 2024 | 11.43% | 6.96 | |
| 31 Jul 2024 | 9.91% | 14.06 | |
| 15 Aug 2024 | 10.08% | 11.04 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 9.15% | 15.13 | |
| 13 Sep 2024 | 8.94% | 11.30 | |
| 30 Sep 2024 | 8.00% | 6.30 | |
| 15 Oct 2024 | 7.77% | 14.36 | |
| 31 Oct 2024 | 7.24% | 7.52 | |
| 15 Nov 2024 | 5.67% | 3.36 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 5.61% | 5.63 | |
| 13 Dec 2024 | 7.08% | 2.23 | |
| 31 Dec 2024 | 6.13% | 4.43 |
See also: CytomX Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.